Evidence map›Paper›PMID 29528457›Full record

ArticleTranslational behavioral medicine2018

Tobacco treatment implementation within 28 commission on cancer accredited programs in the Northeast region of the USA: A pilot study.

Mary E Cooley, Hermine Poghosyan, Kim Sprunck-Harrild, Jonathan P Winickoff, Stephen B Edge, Karen M Emmons

Open access · bronzeAbstract read
In one paragraph

Article in Translational behavioral medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Development and Demonstration of Tobacco Treatment Measures for Cancer Registries: Novel Metrics for Quality Improvement.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  6. Article
  7. The characteristics of patients who quit smoking in the year following a cancer diagnosis.Journal of cancer survivorship : research and practice · 2022
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Mary E CooleyDana-Farber Cancer Institute, Boston, MA, USA.
Hermine PoghosyanNortheastern University School of Nursing, Boston, MA, USA.
Kim Sprunck-HarrildDana-Farber Cancer Institute, Boston, MA, USA.
Jonathan P WinickoffMassachusetts General Hospital, Boston, MA, USA.
Stephen B EdgeAmerican College of Surgeons Commission on Cancer, Chicago, IL, USA.
Karen M EmmonsHarvard T.H. Chan School of Public Health, Boston, MA, USA.
Dana-Farber Cancer Institute · USAmerican College of Surgeons · USHarvard University · USMassachusetts General Hospital · USNortheastern University · US

Funding

A Web-Based Smoking Intervention for Cancer SurvivorsR01CA106914 · NCI · DANA-FARBER CANCER INSTITUTE · PI EMMONS, KAREN M. · 2004 to 2009
$3.0M
Dissemination Research to Reduce Cancer DisparitiesK05CA124415 · NCI · DANA-FARBER CANCER INST · PI EMMONS, KAREN M. · 2007 to 2011
$810k
NCI NIH HHS K05 CA124415NCI NIH HHS R01 CA106914
6 · The paper itself

Abstract

Cancer survivors are a rapidly growing population and an important target for tobacco treatment interventions. Continued smoking after the diagnosis of cancer is associated with a higher risk of cancer recurrence and mortality. Systematic tobacco cessation programs are effective. This study surveyed American College of Surgeons Commission on Cancer (CoC) programs in the Northeast region of the USA regarding their tobacco control programs. Seventy percent of cancer survivors are treated within CoC programs. The purpose of this study was to describe the extent of implementation of tobacco treatment and determine the organizational delivery of tobacco treatment as measured by the presence of goals to address smoking, leadership support, and integration of tobacco treatment guidelines into care delivery. Data were collected by a survey. The Assessment of Chronic Illness Care questionnaire was used to collect data on implementation of tobacco treatment services. Descriptive statistics were used to analyze the data. Most programs (78.6%) had an electronic health record and of these 68% captured smoking status. Implementation of tobacco treatment was not optimal for identifying smokers, providing patients with community linkages or self-care cessation support. Implementation of decision aides for pharmacotherapy and reassessment of smoking status were the least developed areas. Moreover, the organizational delivery for tobacco treatment was less than optimal. Many cancer programs have not implemented systems to deliver optimal tobacco treatment. Efforts should be made to help cancer programs develop sustainable system-wide programs that address the urgent need to deliver tobacco treatment to all cancer survivors.

Indexed as

Cancer SurvivorsProgram DevelopmentProgram EvaluationAdultFemaleHumansMaleNew EnglandPilot ProjectsSmoking CessationTobacco Use CessationTobacco Use Disorder

Identifiers

PMID29528457
PMCPMC6454513
OpenAlexW2790287470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.